Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice

The development of an efficient and safe coronavirus disease 2019 (COVID-19) vaccine is a crucial approach for managing the severe acute respiratory disease coronavirus 2 (SARS-CoV-2) pandemic in light of current conditions. In this study, we produced a shortened segment of the optimized SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Keda, Shi, Danrong, Li, Chaonan, Fang, Zhongbiao, Guo, Yikai, Jiang, Wenjie, Li, Jiaxuan, Li, Hongyu, Yao, Hangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968167/
https://www.ncbi.nlm.nih.gov/pubmed/36851306
http://dx.doi.org/10.3390/vaccines11020429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968167/
https://www.ncbi.nlm.nih.gov/pubmed/36851306
http://dx.doi.org/10.3390/vaccines11020429

Ejemplares similares